104 related articles for article (PubMed ID: 25483979)
21. High-dose atorvastatin reloading before percutaneous coronary intervention increased circulating endothelial progenitor cells and reduced inflammatory cytokine expression during the perioperative period.
Ye H; He F; Fei X; Lou Y; Wang S; Yang R; Hu Y; Chen X
J Cardiovasc Pharmacol Ther; 2014 May; 19(3):290-5. PubMed ID: 24346155
[TBL] [Abstract][Full Text] [Related]
22. Anti-inflammatory effects of simvastatin on adipokines in type 2 diabetic patients with carotid atherosclerosis.
Hu Y; Tong G; Xu W; Pan J; Ryan K; Yang R; Shuldiner AR; Gong DW; Zhu D
Diab Vasc Dis Res; 2009 Oct; 6(4):262-8. PubMed ID: 20368220
[TBL] [Abstract][Full Text] [Related]
23. Bone marrow molecular alterations after myocardial infarction: Impact on endothelial progenitor cells.
Thum T; Fraccarollo D; Galuppo P; Tsikas D; Frantz S; Ertl G; Bauersachs J
Cardiovasc Res; 2006 Apr; 70(1):50-60. PubMed ID: 16480696
[TBL] [Abstract][Full Text] [Related]
24. Improvement of endothelial damage and regeneration indexes in patients with coronary artery disease after 4 weeks of statin therapy.
Schmidt-Lucke C; Fichtlscherer S; Rössig L; Kämper U; Dimmeler S
Atherosclerosis; 2010 Jul; 211(1):249-54. PubMed ID: 20211468
[TBL] [Abstract][Full Text] [Related]
25. Pooled analyses of effects on C-reactive protein and low density lipoprotein cholesterol in placebo-controlled trials of ezetimibe monotherapy or ezetimibe added to baseline statin therapy.
Pearson TA; Ballantyne CM; Veltri E; Shah A; Bird S; Lin J; Rosenberg E; Tershakovec AM
Am J Cardiol; 2009 Feb; 103(3):369-74. PubMed ID: 19166691
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
[TBL] [Abstract][Full Text] [Related]
27. Alterations of plant sterols, lathosterol, oxidative stress and inflammatory markers after the combination therapy of ezetimibe and statin drugs in type 2 diabetic patients.
Naruse R; Hori K; Terasawa T; Hara K; Suetsugu M; Takebayashi K; Morita K; Aso Y; Inukai T
Obes Res Clin Pract; 2015; 9(1):67-74. PubMed ID: 25660177
[TBL] [Abstract][Full Text] [Related]
28. Circulating Progenitor Cell Count Predicts Microvascular Outcomes in Type 2 Diabetic Patients.
Rigato M; Bittante C; Albiero M; Avogaro A; Fadini GP
J Clin Endocrinol Metab; 2015 Jul; 100(7):2666-72. PubMed ID: 25942480
[TBL] [Abstract][Full Text] [Related]
29. Rebound inflammatory response during the acute phase of myocardial infarction after simvastatin withdrawal.
Sposito AC; Carvalho LS; Cintra RM; Araújo AL; Ono AH; Andrade JM; Coelho OR; Quinaglia e Silva JC;
Atherosclerosis; 2009 Nov; 207(1):191-4. PubMed ID: 19464010
[TBL] [Abstract][Full Text] [Related]
30. Achieving goal lipid levels with ezetimibe plus statin add-on or switch therapy compared with doubling the statin dose. A pooled analysis.
Ambegaonkar BM; Tipping D; Polis AB; Tomassini JE; Tershakovec AM
Atherosclerosis; 2014 Dec; 237(2):829-37. PubMed ID: 25463129
[TBL] [Abstract][Full Text] [Related]
31. HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells.
Llevadot J; Murasawa S; Kureishi Y; Uchida S; Masuda H; Kawamoto A; Walsh K; Isner JM; Asahara T
J Clin Invest; 2001 Aug; 108(3):399-405. PubMed ID: 11489933
[TBL] [Abstract][Full Text] [Related]
32. Effect of low-density lipoprotein apheresis on circulating endothelial progenitor cells in familial hypercholesterolemia.
Ramunni A; Brescia P; Dambra P; Capuzzimati L; Ria R; De Tullio G; Resta F; Russi G; Vacca A; Coratelli P
Blood Purif; 2010; 29(4):383-9. PubMed ID: 20484899
[TBL] [Abstract][Full Text] [Related]
33. Impaired development and dysfunction of endothelial progenitor cells in type 2 diabetic mice.
Tsukada S; Masuda H; Jung SY; Yun J; Kang S; Kim DY; Park JH; Ji ST; Kwon SM; Asahara T
Diabetes Metab; 2017 Apr; 43(2):154-162. PubMed ID: 27638126
[TBL] [Abstract][Full Text] [Related]
34. Continuation of statin therapy in patients with presumed infection: a randomized controlled trial.
Kruger PS; Harward ML; Jones MA; Joyce CJ; Kostner KM; Roberts MS; Venkatesh B
Am J Respir Crit Care Med; 2011 Mar; 183(6):774-81. PubMed ID: 20959555
[TBL] [Abstract][Full Text] [Related]
35. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
Querton L; Buysschaert M; Hermans MP
J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
[TBL] [Abstract][Full Text] [Related]
36. Regulation of human endothelial progenitor cell maturation by polyurethane nanocomposites.
Hung HS; Yang YC; Lin YC; Lin SZ; Kao WC; Hsieh HH; Chu MY; Fu RH; Hsu SH
Biomaterials; 2014 Aug; 35(25):6810-21. PubMed ID: 24836305
[TBL] [Abstract][Full Text] [Related]
37. Effects of ezetimibe add-on to statin therapy on adipokine production in patients with metabolic syndrome and stable vascular disease.
Gupta M; Szmitko PE; Tsigoulis M; Braga MF; Kajil M; Herjikaka S; Quan A; Teoh H; Verma S
J Cardiovasc Pharmacol; 2010 Sep; 56(3):241-5. PubMed ID: 20505518
[TBL] [Abstract][Full Text] [Related]
38. Influence of short-term rosuvastatin therapy on endothelial progenitor cells and endothelial function.
Pirro M; Schillaci G; Romagno PF; Mannarino MR; Bagaglia F; Razzi R; Pasqualini L; Vaudo G; Mannarino E
J Cardiovasc Pharmacol Ther; 2009 Mar; 14(1):14-21. PubMed ID: 19158317
[TBL] [Abstract][Full Text] [Related]
39. The gap between the current dyslipidemia guidelines and the physicians' treatment targets in patients with type 2 diabetes in Turkey.
Kahya Eren N; Harman E; Dolek D; Emren S; Tütüncüoğlu AP; Nazli C; Ergene O
Minerva Cardioangiol; 2014 Jun; 62(3):287-95. PubMed ID: 24831765
[TBL] [Abstract][Full Text] [Related]
40. How to reach LDL targets quickly in patients with diabetes or metabolic syndrome.
Leiter LA; Martineau P; de Teresa E; Farsang C; Gaw A; Gensini G; Langer A;
J Fam Pract; 2008 Oct; 57(10):661-8. PubMed ID: 18842192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
